logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Premenstrual Dysphoric Disorder

    Medications for Premenstrual Dysphoric Disorder

    FiltersReset Filters
    11 results

    • drospirenone and ethinyl estradiol

      (drospirenone and ethinyl estradiol)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Drospirenone and ethinyl estradiol tablets are indicated for pregnancy prevention, treatment of premenstrual dysphoric disorder (PMDD) in women choosing oral contraception, and treatment of moderate acne vulgaris in women aged 14 and older desiring birth control. Long-term effectiveness for PMDD is not evaluated beyond three cycles.

    • drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium

      (drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium)
      Lupin Pharmaceuticals, Inc.
      Usage: Drospirenone, ethinyl estradiol, and levomefolate calcium tablets are indicated for preventing pregnancy, treating premenstrual dysphoric disorder (PMDD), moderate acne in females of reproductive potential, and providing folate supplementation to reduce neural tube defect risks in pregnancies conceived while using or shortly after discontinuing the medication.

    • jasmiel

      (Drospirenone and Ethinyl Estradiol)
      Afaxys Pharma, LLC
      Usage: Jasmiel® is indicated for preventing pregnancy in females of reproductive potential, treating premenstrual dysphoric disorder (PMDD) for those who choose contraception, and managing moderate acne vulgaris in women aged 14 and older seeking oral contraceptive therapy. Effectiveness for PMDD beyond three cycles remains unproven.

    • lo-zumandimine

      (Drospirenone and Ethinyl Estradiol)
      Aurobindo Pharma Limited
      Usage: Lo-Zumandimine is indicated for pregnancy prevention in females of reproductive potential. It also treats premenstrual dysphoric disorder (PMDD) symptoms and moderate acne vulgaris in women aged 14 and older, provided they seek oral contraception. Effectiveness for PMDD beyond three menstrual cycles is not evaluated.

    • nikki

      (drospirenone and ethinyl estradiol)
      Lupin Pharmaceuticals, Inc.
      Usage: Nikki™ (drospirenone and ethinyl estradiol) is indicated for pregnancy prevention in females of reproductive potential, treatment of premenstrual dysphoric disorder (PMDD) when used as contraception, and treatment of moderate acne vulgaris in women aged 14 and older who also desire birth control.

    • sertraline hydrochloride

      (Sertraline hydrochloride)
      Granules Pharmaceuticals Inc.
      Usage: Sertraline hydrochloride tablets are indicated for treating major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.

    • sertraline hydrochloride

      (SERTRALINE HYDROCHLORIDE)
      Accord Healthcare, Inc.
      Usage: Sertraline hydrochloride is indicated for treating major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, social anxiety disorder, and premenstrual dysphoric disorder.

    • sertraline hydrochloride

      (sertraline hydrochloride)
      Camber Pharmaceuticals, Inc.
      Usage: Sertraline hydrochloride tablets are indicated for treating major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder (PD), posttraumatic stress disorder (PTSD), social anxiety disorder (SAD), and premenstrual dysphoric disorder (PMDD).

    • sertraline hydrochloride

      (SERTRALINE HYDROCHLORIDE)
      ACI Healthcare USA, Inc.
      Usage: Sertraline hydrochloride tablets are indicated for treating major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder (PD), post-traumatic stress disorder (PTSD), social anxiety disorder (SAD), and premenstrual dysphoric disorder (PMDD).

    • vestura

      (Drospirenone and Ethinyl Estradiol)
      Teva Pharmaceuticals Inc
      Usage: Vestura (drospirenone and ethinyl estradiol) is indicated to prevent pregnancy in females of reproductive potential, treat premenstrual dysphoric disorder (PMDD) for those choosing it as contraception, and manage moderate acne in women aged 14 and older, provided they seek oral contraceptive benefits.